Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
for Metastatic Non-Squamous Non-Small Cell Lung Cancer
Drug: Nivolumab
Sites in Los Angeles +3 more locations
Sponsor: CatalYm GmbH
Sex: All·Age: 18+
Code: NCT07246863·Phase 2·Recruiting·Listed Nov 2025